- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04199130
Cognitive Rehabilitation and Brain Activity of Attention-Control Impairment in TBI
Effectiveness of Combined Attention and Metacognitive-strategy Training Approaches to Cognitive Impairment in Moderate-to-severe TBI
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study will compare the effectiveness of two different types of cognitive rehabilitation in moderate-to-severe (m/s) traumatic brain injury (TBI) survivors. More specifically comparisons will be made between Direct Attention Training administered via BrainHQ, and Metacognitive Strategy Training in the form of the evidence-based Goal Management Training (GMT) protocol.
These interventions will be compared to the standard of care, to each other, and their combined effectiveness will be assessed. Groups will consist of randomized individuals with moderate-to-severe TBIs who experience attention deficits. Each treatment will be administered for 4 weeks and two intervention groups will be used to counterbalance treatment order. Group 1 will receive BrainHQ first followed by GMT, while Group 2 will receive GMT first followed by BrainHQ. In addition a third group will serve as a treatment-as-usual control group.
Primary outcomes include measures of self-care, ability, adjustment and participation. Secondary outcomes include measures of cognition and brain function. And lastly, tertiary outcomes include measures of emotional and psychosocial functioning. These outcomes will be measures at baseline, following completion of the first 4 week treatment in both groups (Group 1 = BrainHQ while Group 2 = GMT), and following completion of the second 4 week treatment in both groups (Group 1 = GMT while Group 2 = BrainHQ).
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Florida
-
Gainesville, Florida, United States, 32611
- College of Public Health and Health Professions, University of Florida
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Self-report of attention problems, confirmed with psychometric testing
- Ruff 2 & 7 selective attention task score ≤ 1.5 standard deviations from demographically-matched norms
- Able to participate in study at 12-60 months post-injury without contraindications
- Willingness to be randomized and to participate in treatment procedures
- Capacity to visit the laboratory for repeated treatment sessions and testing
- Access to internet-enabled home computer
- English as native language
- Adequate reading comprehension to allow completion of questionnaires
- Reliable digit span (RDS) score > 7
Exclusion Criteria:
- Pre-existing neurological disorder associated with cerebral dysfunction (e.g., stroke, history of epilepsy or chronic seizure disorder)
- Current alcohol or drug use
- Pre-existing severe psychiatric disorder (e.g., schizophrenia) detected by Mental Screening form, 3rd edition (MHS-III) or history of psychiatric diagnosis sufficiently severe to have resulted in inpatient hospitalization
- Current suicidal/homicidal ideation or intent
- Reported involvement in current litigation
- Reported history of pre-injury learning disability
- Not competent to provide written informed consent (i.e., not able to demonstrate understanding or expectations of study and potential risks of participation)
- Does not fully understand the nature of the study and requirements of participation
- Does not understand task instructions
- Validity testing (score ≤ 7) on the RDS 22 test of suboptimal/non-credible performance taken from the forward and backward digit span subtests of the WAIS-IV
Study Plan
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Intervention Group 1
This arm will receive BrainHQ for the first four weeks of the study, and Goal Management Training for the second four weeks.
|
BrainHQ is a web-based "brain-training" program.
The investigators will assign participants to attention specific modules that they will complete at home with the goal of "restoring" attentional functions lost through injury via repetitive tasks of graded difficulty.
This is a manualized, interactive, metacognitive-strategy training designed to promote a mindful approach to complex real-life tasks and reduce lapses in attention via implementation of "compensatory" mechanisms for monitoring tasks.
|
EXPERIMENTAL: Intervention Group 2
This arm will receive Goal Management Training for the first four weeks of the study, and BrainHQ for the second four weeks.
|
BrainHQ is a web-based "brain-training" program.
The investigators will assign participants to attention specific modules that they will complete at home with the goal of "restoring" attentional functions lost through injury via repetitive tasks of graded difficulty.
This is a manualized, interactive, metacognitive-strategy training designed to promote a mindful approach to complex real-life tasks and reduce lapses in attention via implementation of "compensatory" mechanisms for monitoring tasks.
|
NO_INTERVENTION: Treatment-as-usual
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Measurement of change in self-care
Time Frame: Measured at Baseline, Post treatment 1 (4 weeks post-baseline), Post treatment 2 (8 weeks post baseline)
|
These will be measured via the Timed Instrumental Activities of Daily Living assessment.
Participants will be timed performing common functional tasks and longer completion times indicate greater impairment.
|
Measured at Baseline, Post treatment 1 (4 weeks post-baseline), Post treatment 2 (8 weeks post baseline)
|
Measurement of change in ability, adjustment and participation
Time Frame: Measured at Baseline, Post treatment 1 (4 weeks post-baseline), Post treatment 2 (8 weeks post baseline)
|
A composite self-report questionnaire known as the Mayo-Portland Adaptability Inventory will be used to measure functioning across these domains.
This measures uses a scale from 0 to 4. The higher the score the more severe the impairment.
|
Measured at Baseline, Post treatment 1 (4 weeks post-baseline), Post treatment 2 (8 weeks post baseline)
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ANTICIPATED)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB201902218
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Traumatic Brain Injury
-
Fondazione per la Ricerca Ospedale MaggioreCompletedBrain Injuries, Traumatic | Brain Injury Traumatic Severe | Brain Injury Traumatic ModerateItaly
-
Toronto Rehabilitation InstituteCentre for Aging and Brain Health Innovation; Ontario Neurotrauma FoundationUnknownBrain Injuries, Traumatic | Brain Injury, Chronic | Brain Injury Traumatic Severe | Brain Injury Traumatic ModerateCanada
-
Hospital Sirio-LibanesUniversity of Sao Paulo; Ministry of Health, Brazil; Hospital Sao Rafael; PROAD... and other collaboratorsRecruitingBrain Injury Traumatic Severe | Brain Injury Traumatic Moderate | Post Traumatic EpilepsyBrazil
-
University of TurkuTurku University Hospital; The Finnish Funding Agency for Technology and Innovation... and other collaboratorsCompletedBrain Injuries | TBI (Traumatic Brain Injury) | Brain Injuries, Traumatic | Traumatic Brain Injury | Injury, Brain, TraumaticFinland
-
Children's Hospital Medical Center, CincinnatiUniversity of CincinnatiCompletedBrain Injury Traumatic MildUnited States
-
BrainScope Company, Inc.RecruitingTBI (Traumatic Brain Injury) | Concussion, Brain | MTBI - Mild Traumatic Brain Injury | Closed Head InjuryUnited States
-
Institut National de la Santé Et de la Recherche...Institut National de Recherche en Informatique et en AutomatiqueNot yet recruitingTBI (Traumatic Brain Injury)France
-
University of Sao Paulo General HospitalUnknownTraumatic Brain Injury | Severe Brain Injury | Closed Traumatic Brain InjuryBrazil
-
First Affiliated Hospital Xi'an Jiaotong UniversityXijing Hospital; Second Affiliated Hospital of Wenzhou Medical University; Central... and other collaboratorsRecruitingMTBI - Mild Traumatic Brain Injury | Moderate Traumatic Brain InjuryChina
-
First Affiliated Hospital Xi'an Jiaotong UniversityHealth Science Center of Xi'an Jiaotong University; The Second Affiliated Hospital...RecruitingMTBI - Mild Traumatic Brain InjuryChina
Clinical Trials on BrainHQ
-
University of NebraskaCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
NYU Langone HealthRecruitingTraumatic Brain InjuryUnited States
-
Duke UniversityEnrolling by invitationLong COVID | Long Covid19 | Long Covid-19United States
-
Duke UniversityEnrolling by invitationLong COVID | Long Covid19 | Long Covid-19United States
-
Rotman Research Institute at BaycrestUniversity of TorontoUnknown
-
DHR Health Institute for Research and DevelopmentWithdrawnQuality of Life | Cognitive Impairment | Subarachnoid Hemorrhage | Depression, AnxietyUnited States
-
Aristotle University Of ThessalonikiCompleted
-
New York Institute of TechnologyCompletedParkinson DiseaseUnited States
-
University of MinnesotaNational Institute of Mental Health (NIMH)RecruitingPsychotic Disorders | Schizophrenia | Schizophrenia Spectrum and Other Psychotic Disorders | Schizoaffective Disorder | Psychosis | Schizo Affective Disorder | Schizophreniform Disorders | Psychoses, Affective | Psychotic Mood Disorders | Psychosis Nos/OtherUnited States
-
Florida State UniversityCompletedCognitive AgingUnited States